Comparison of Focused and Radial Extracorporeal Shock Wave for Carpal Tunnel Syndrome
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Carpal Tunnel Syndrome
- Sponsor
- Tri-Service General Hospital
- Locations
- 1
- Primary Endpoint
- Change from baseline of Boston Carpal Tunnel Syndrome Questionnaire (BCTQ) at 24th weeks after treatment
- Status
- Withdrawn
- Last Updated
- 4 years ago
Overview
Brief Summary
Extracorporeal shock wave is a novel treatment for peripheral nerve entrapment. This study was designed to compare the efficacy of focused and radial extracorporeal shock wave for carpal tunnel syndrome.
Detailed Description
Both focused and radial extracorporeal shock wave had been proved to treat carpal tunnel syndrome by several studies. However, there was no study comparing these two methods. Considering different mechanisms and costs, this randomized comparative trial would be conducted to compare the efficacy of focused and radial extracorporeal shock wave for carpal tunnel syndrome.
Investigators
Yung-Tsan Wu
Principal Investigator
Tri-Service General Hospital
Eligibility Criteria
Inclusion Criteria
- •Clinical and electrophysiological diagnosis of CTS
Exclusion Criteria
- •Cervical radiculopathy
- •Polyneuropathy
- •Brachial plexopathy
- •Thoracic outlet syndrome
- •Previous wrist surgery or steroid injection for CTS
Outcomes
Primary Outcomes
Change from baseline of Boston Carpal Tunnel Syndrome Questionnaire (BCTQ) at 24th weeks after treatment
Time Frame: Change of the mean of total SSS and FSS from baseline at 24th weeks after treatment
Boston carpal tunnel syndrome questionnaire (BCTQ) is a frequently used patient-based questionnaire for measurement of carpal tunnel syndrome which encompasses two components. eleven questions and eight items were evaluated to rate the symptom severity scale (SSS) and functional status scale (FSS), respectively. Each question or item ranges from 1 to 5 with a higher score indicating severer symptom or a higher degree of disability. Total score of SSS ranges from 11-55 and FSS from 8-40. The mean of total SSS and FSS divided with each item score were used for further analysis.
Secondary Outcomes
- Cross-sectional area (CSA) of the median nerve(Pre-treatment, 2nd, 4th, 8th, 12th and 24th weeks after treatment)
- Nerve conduction amplitude(Pre-treatment, 2nd, 4th, 8th, 12th and 24th weeks after treatment)
- Nerve conduction velocity(Pre-treatment, 2nd, 4th, 8th, 12th and 24th weeks after treatment)
- Visual analogue scale (VAS)(Pre-treatment, 2nd, 4th, 8th, 12th and 24th weeks after treatment)